Christopher Liu

Stock Analyst at Leerink Partners

(2.50)
# 2,300
Out of 4,893 analysts
5
Total ratings
50%
Success rate
24.55%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Christopher Liu

Relay Therapeutics
Dec 4, 2024
Maintains: Outperform
Price Target: $19$18
Current: $3.60
Upside: +400.00%
IDEAYA Biosciences
Nov 5, 2024
Downgrades: Market Perform
Price Target: $41$27
Current: $22.63
Upside: +19.31%
Nuvalent
Aug 8, 2023
Initiates: Market Perform
Price Target: $42
Current: $81.74
Upside: -48.62%
Exelixis
Aug 8, 2023
Initiates: Market Perform
Price Target: $18
Current: $45.39
Upside: -60.34%